Information according to Annex 4 of Ordinance 2 as at 31 December 2022
Declaration by the responsible directors as at 31 December 2022
Consolidated financial report according to IFRS as at 31 December 2022 - Excel
Notification for share participation from “Telso” AD
Sofia, Bulgaria, February 21, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that today the Company received a notification for participation from “Telso” AD, UIC 131176385. As a result of the accepted tender offer, "Telso" AD is reduced below the threshold from 5% to 1.44% in the capital of "Sopharma" AD.
Notification for share participation from “Donev investments holding” AD
Sofia, Bulgaria, February 21, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that today the Company received a notification for participation from “Donev investments holding, UIC 831915121. As a result of acquired shares following a tender offer made by "Donev Investments Holding" AD to the shareholders of "Sopharma" AD, "Donev Investments Holding" AD increases its direct participation in the capital of the Company to 35.24%, crossing the threshold of 35%.
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 17 February 2023.
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 20 February 2023.
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 17 February 2023.
Sales revenues for January 2023
Sofia, Bulgaria, February 6, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for January 2023 the Company recorded an increase in sales of 33% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 174% increase in export sales.